Debiopharm Innovation Fund Launches New Seed Funding Activity to Accelerate Digital Transformation
Kicks off fund with two strategic investments Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, with $150 million under management, announced the launch of its new seed funding initiative. It plans to deploy additional capital to support up to 15 seed-stage startups each year. Building on......